Registered entity data
In general | |||
| Enterprise number: | 0667.779.672 | ||
| Status: | Active | ||
| Legal situation: | Normal situation Since December 16, 2016 | ||
| Start date: | December 16, 2016 | ||
| Name: | MD Pharma Name in Dutch, since November 22, 2018 | ||
| Registered seat's address: |
Kortrijksesteenweg 1091
box B
9051 Gent Since January 25, 2022 | ||
| Phone number: | No data included in CBE. | ||
| Fax: | No data included in CBE. | ||
| Email address: | No data included in CBE. | ||
| Web Address: | No data included in CBE. | ||
| Entity type: | Legal person | ||
| Legal form: |
Public limited company
Since December 16, 2016 | ||
| Number of establishment units (EU): | 1
Information and activities for each establishment unit | ||
| | |||
Functions | |||
| Director | 0471.608.456 | Since April 1, 2017 | |
| Director | 0666.678.822 | Since April 23, 2019 | |
| Permanent representative | Debel , Mario (0471.608.456) | Since April 1, 2017 | |
| Permanent representative | Imschoot , Anja (0666.678.822) | Since April 23, 2019 | |
| Managing Director | 0471.608.456 | Since April 1, 2017 | |
| | |||
Entrepreneurial skill - Travelling- Fairground operator | |||
| Knowledge of basic management Since December 22, 2016 | |||
| | |||
Characteristics | |||
| Subject to VAT Since December 16, 2016 | |||
| Enterprise subject to registration Since November 1, 2018 | |||
| | |||
Authorisations | |||
| Knowledge of basic business management Since December 22, 2016 | |||
| | |||
Version of the Nacebel codes for the VAT activities 2008(1) | |||
| VAT 2008
77.400 -
Leasing of intellectual property and similar products, except copyrighted works Since July 1, 2018 | |||
| | |||
Financial information | |||
| Capital | 1.087.000,00 EUR | ||
| Annual assembly | June | ||
| End date financial year | 31 December | ||
| Start date exceptional fiscal year | December 15, 2016 | ||
| End date exceptional fiscal year | December 31, 2017 | ||
| | |||
Links between entities | |||
| 0465.573.571 (CALXX LABORATORIES)
has been absorbed by this entity
since November 22, 2018 | |||
| 0643.996.361 (MD PHARMA)
has been absorbed by this entity
since November 22, 2018 | |||
| 0655.920.136 (Primrose Pharma)
has been absorbed by this entity
since November 22, 2018 | |||
| | |||
External links | |||
|
Publications in National Gazette
Publication of the annual accounts in the Central Balance Sheet Office Database of statutes and powers of representation (notarial deeds) | |||
(1)Activities are registered in the CBE using NACE-BEL codes (Belgian classification of activities). There are different versions of these codes. Activities with a NACE-BEL code (version 2003) were stopped on 31/12/2007 and automatically converted to the new NACE-BEL codes (2008 version) starting on 01/01/2008. A new 2025 version of the codes will enter into force on 01/01/2025. During the first half of the year 2025, all activities with a 2008 version of the NACE-BEL code will be phased out with 31/12/2024 as end date and automatically converted to the 2025 version of the NACE-BEL codes, starting on 01/01/2025. Up until then, activities will continue to be registered using the 2008 NACE-BEL codes.
To top Back
